The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear

Cassandra P. Loren, Joseph E. Aslan, Rachel A. Rigg, Marie S. Nowak, Laura D. Healy, András Gruber, Brian J. Druker, Owen J.T. McCarty

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear'. Together they form a unique fingerprint.

Medicine & Life Sciences